India’s pharma industry grows 7.8% in April; government says, ‘success of smart schemes’

India’s pharmaceutical sector is experiencing rapid growth, with a 7.8% year-on-year increase in April 2025, driven by strong domestic demand and new product introductions. The country is a leading global supplier of generic medicines and vaccines, with government attributing its initiatives like the PMBJP and PLI schemes. Foreign investment is also robust, making India an attractive destination for pharmaceutical enterprises.